Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Insulet

Explore full profile

OmniPod | A convenient way to help manage diabetes

Acton, United StatesFounded 2000Biotech & Life Sciences
Valuation $12B Market cap · Aug/2026
Revenue $3.32B Latest reported FY
EBITDA $810M Latest reported FY

At a glance

Status
Listed
Founded
2000
Headquarters
Acton, United States
Listing
IPO 2007
Sector
Biotech & Life Sciences
Power Law
Decacorn$10B+ valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Prism Venture Management

Series B and later11 investors entered at this stage

  • OrbiMed
  • Oakwood Medical Investors
  • Longitude Capital
  • Alta Partners
  • SV Health Investors
  • Versant Ventures
  • SightLine Partners
  • MedVenture Associates
  • Red Abbey Venture Partners
  • TIAA
  • Aphelion Capital

Talent

Book a demo to see the people
Employees mapped 5,370 incl. 16 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 11 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
31 countries with
team presence
🇺🇸 United States67.7%
🇲🇽 Mexico14.2%
🇬🇧 United Kingdom5.2%
🇲🇾 Malaysia2.9%
🇨🇦 Canada2.2%
Top 5 of 31 shown
Web traffic by country
140K monthly visits
across markets
🇺🇸 United States52.1%
🇲🇽 Mexico27.1%
🇬🇧 United Kingdom7.3%
🇩🇪 Germany1.9%
🇨🇦 Canada1.9%
Top 5 markets shown

Patents

Estimated portfolio value
$315M

493 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Insulet was the backer or acquirer, 2011–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

2 deals across Insulet's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Insulet deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Insulet's portfolio, mapped.

        Stage
        Period
        2 of 2 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Insulet on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Insulet on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles